Cristina E. Tognon

10.9k total citations · 2 hit papers
81 papers, 3.6k citations indexed

About

Cristina E. Tognon is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Cristina E. Tognon has authored 81 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 37 papers in Hematology and 30 papers in Oncology. Recurrent topics in Cristina E. Tognon's work include Acute Myeloid Leukemia Research (27 papers), Chronic Myeloid Leukemia Treatments (19 papers) and PI3K/AKT/mTOR signaling in cancer (11 papers). Cristina E. Tognon is often cited by papers focused on Acute Myeloid Leukemia Research (27 papers), Chronic Myeloid Leukemia Treatments (19 papers) and PI3K/AKT/mTOR signaling in cancer (11 papers). Cristina E. Tognon collaborates with scholars based in United States, Canada and Brazil. Cristina E. Tognon's co-authors include Poul H. Sorensen, Valentina Evdokimova, Brian Druker, Heather Kirk, Ian P. Whitehead, Robert J. Kay, Jeffrey Tyner, Joan Mathers, Tony Ng and Calvin D. Roskelley and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Cristina E. Tognon

76 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma

2002 672 citations Cristina E. Tognon, Calvin D. Roskelley et al. profile →
OncogenicCSF3RMutations in Chronic Neutrophilic Leukemia and Atypical CML

2013 356 citations Julia E. Maxson, Anupriya Agarwal et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cristina E. Tognon United States	26	2.0k	980	705	691	509	81	3.6k
Max Chaffanet France	36	2.4k 1.2×	1.5k 1.5×	1.0k 1.5×	953 1.4×	464 0.9×	105	4.4k
Sílvia Menéndez United States	32	2.5k 1.3×	1.2k 1.2×	903 1.3×	430 0.6×	532 1.0×	76	4.0k
Norihiko Kawamata Japan	38	2.2k 1.1×	1.4k 1.4×	588 0.8×	745 1.1×	314 0.6×	96	4.0k
Roland P. Kuiper Netherlands	35	2.6k 1.3×	1.1k 1.1×	1.1k 1.6×	1.5k 2.2×	513 1.0×	123	5.4k
Todd Hembrough United States	25	942 0.5×	880 0.9×	653 0.9×	398 0.6×	524 1.0×	71	2.3k
José A. Martínez-Climent Spain	39	1.9k 0.9×	1.3k 1.3×	784 1.1×	952 1.4×	483 0.9×	135	4.5k
Dmitri Wiederschain United States	28	2.5k 1.2×	1.6k 1.6×	1.2k 1.7×	453 0.7×	330 0.6×	45	3.8k
Michael T. Barrett United States	34	1.9k 0.9×	1.4k 1.4×	1.1k 1.5×	420 0.6×	840 1.7×	99	4.2k
Kolja Eppert Canada	16	1.8k 0.9×	841 0.9×	491 0.7×	985 1.4×	235 0.5×	27	3.1k
Doris Steinemann Germany	31	1.6k 0.8×	551 0.6×	505 0.7×	445 0.6×	174 0.3×	127	2.8k

Countries citing papers authored by Cristina E. Tognon

Since Specialization

Citations

This map shows the geographic impact of Cristina E. Tognon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cristina E. Tognon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cristina E. Tognon more than expected).

Fields of papers citing papers by Cristina E. Tognon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cristina E. Tognon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cristina E. Tognon. The network helps show where Cristina E. Tognon may publish in the future.

Co-authorship network of co-authors of Cristina E. Tognon

This figure shows the co-authorship network connecting the top 25 collaborators of Cristina E. Tognon. A scholar is included among the top collaborators of Cristina E. Tognon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cristina E. Tognon. Cristina E. Tognon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Eide, Christopher A., Stephen E. Kurtz, Nicola Long, et al.. (2026). DDX41-Mutated AML: A Case Report and Perspectives. JCO Precision Oncology. 10(1). e2500992–e2500992.

Sanford, James, Yang Wang, Joshua Hansen, et al.. (2021). Evaluation of Differential Peptide Loading on Tandem Mass Tag-Based Proteomic and Phosphoproteomic Data Quality. Journal of the American Society for Mass Spectrometry. 33(1). 17–30. 1 indexed citations

Eide, Christopher A., Stephen E. Kurtz, Andy Kaempf, et al.. (2020). Simultaneous kinase inhibition with ibrutinib and BCL2 inhibition with venetoclax offers a therapeutic strategy for acute myeloid leukemia. Leukemia. 34(9). 2342–2353. 16 indexed citations

Coelho‐Silva, Juan Luiz, Renata Scopim‐Ribeiro, Priscila Santos Scheucher, et al.. (2020). NT157 has antineoplastic effects and inhibits IRS1/2 and STAT3/5 in JAK2V617F-positive myeloproliferative neoplasm cells. Signal Transduction and Targeted Therapy. 5(1). 5–5. 24 indexed citations

Nechiporuk, Tamilla, Stephen E. Kurtz, Olga Nikolova, et al.. (2019). The TP53 Apoptotic Network Is a Primary Mediator of Resistance to BCL2 Inhibition in AML Cells. Cancer Discovery. 9(7). 910–925. 222 indexed citations

Rozanov, Dmitri V., Anton Cheltsov, Aaron Nilsen, et al.. (2019). Targeting mitochondria in cancer therapy could provide a basis for the selective anti-cancer activity. PLoS ONE. 14(3). e0205623–e0205623. 18 indexed citations

Tognon, Cristina E., Bo Rafn, Naniye Mallı Cetinbas, et al.. (2018). Insulin-like growth factor 1 receptor stabilizes the ETV6–NTRK3 chimeric oncoprotein by blocking its KPC1/Rnf123-mediated proteasomal degradation. Journal of Biological Chemistry. 293(32). 12502–12515. 13 indexed citations

Machado‐Neto, João Agostinho, Renata Scopim‐Ribeiro, Christopher A. Eide, et al.. (2018). Metformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasms. Cell Death and Disease. 9(3). 311–311. 19 indexed citations

Rosenberg, Mara, Cristina E. Tognon, Kevin Watanabe‐Smith, & Uma Borate. (2018). RGL4 over Expression Correlates with Variation in Midostaurin Response in FLT3-ITD Mutant AML Samples. Blood. 132(Supplement 1). 1365–1365. 1 indexed citations

10.

Khanna, Vishesh, Christopher A. Eide, Cristina E. Tognon, et al.. (2017). Recurrent cyclin D2 mutations in myeloid neoplasms. Leukemia. 31(9). 2005–2008. 10 indexed citations

11.

Watanabe‐Smith, Kevin, et al.. (2017). Analysis of acquired mutations in transgenes arising in Ba/F3 transformation assays: findings and recommendations. Oncotarget. 8(8). 12596–12606. 8 indexed citations

12.

Maxson, Julia E., Monika A. Davare, Samuel B. Luty, et al.. (2015). Therapeutically Targetable ALK Mutations in Leukemia. Cancer Research. 75(11). 2146–2150. 17 indexed citations

13.

Watanabe‐Smith, Kevin, Cristina E. Tognon, Jeffrey Tyner, Brian Druker, & Anupriya Agarwal. (2015). A Novel, Oncogenic CSF2RB Mutation Found in a Primary Leukemia Sample Results in Constitutive Signaling, Increased Receptor Stability, and Formation of Intermolecular Complexes. Blood. 126(23). 3670–3670.

14.

Lamble, Adam J., Yoko Kosaka, Pierrette Lo, et al.. (2015). Defining the Immune Microenvironment in Patients with Acute Myeloid Leukemia. Blood. 126(23). 1374–1374. 1 indexed citations

15.

Tarlock, Katherine, et al.. (2015). Novel Method to Perform Functional Drug Screens on Frozen Primary Leukemia Samples. Blood. 126(23). 3248–3248. 1 indexed citations

16.

Yu, Carol, et al.. (2013). Expression of Myoferlin in Human and Murine Carcinoma Tumors. American Journal Of Pathology. 182(5). 1900–1909. 39 indexed citations

17.

El-Naggar, Amal M., Paul W. Clarkson, Fan Zhang, et al.. (2012). Expression and stability of hypoxia inducible factor 1α in osteosarcoma. Pediatric Blood & Cancer. 59(7). 1215–1222. 34 indexed citations

18.

Tognon, Cristina E. & Poul H. Sorensen. (2012). Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy. Expert Opinion on Therapeutic Targets. 16(1). 33–48. 93 indexed citations

19.

Evdokimova, Valentina, Cristina E. Tognon, & Poul H. Sorensen. (2012). On translational regulation and EMT. Seminars in Cancer Biology. 22(5-6). 437–445. 25 indexed citations

20.

Tognon, Cristina E., Aruna M. Somasiri, Valentina Evdokimova, et al.. (2010). ETV6-NTRK3–Mediated Breast Epithelial Cell Transformation Is Blocked by Targeting the IGF1R Signaling Pathway. Cancer Research. 71(3). 1060–1070. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact